Common metabolic features of hypertension and type 2 diabetes

被引:0
作者
Isao Usui
机构
[1] Dokkyo Medical University,Department of Endocrinology and Metabolism
来源
Hypertension Research | 2023年 / 46卷
关键词
Hypertension; Type 2 diabetes; Obesity; Insulin resistance; Sympathetic nerve;
D O I
暂无
中图分类号
学科分类号
摘要
Hypertension and type 2 diabetes frequently coexist, suggesting that the two diseases have common pathophysiological bases. This review describes the pathophysiological mechanisms of how type 2 diabetes is frequently associated with hypertension. Multiple common factors mediate between both diseases. Factors that induce both type 2 diabetes and hypertension include obesity-induced hyperinsulinemia, activation of the sympathetic nervous system, chronic inflammation, and changes in adipokines. Vascular complications resulting from type 2 diabetes and hypertension include endothelial dysfunction, vasodilation/constriction dysfunction of peripheral vessels and increased peripheral vascular resistance, arteriosclerosis, and chronic kidney disease. While many of these vascular complications are caused by hypertension, they also exacerbate the pathology of hypertension. In addition, insulin resistance in the vasculature blunts insulin-induced vasodilation and blood flow to skeletal muscle, which contributes to impaired glucose uptake to skeletal muscle and glucose intolerance. In obese and insulin-resistant patients, increase in the circulating fluid volume forms the major pathophysiology of elevated blood pressure. On the other hand, in non-obese and/or insulin-deficient patients, especially those in the middle- or later stages of diabetes, peripheral vascular resistance is the major pathophysiology of hypertension.
引用
收藏
页码:1227 / 1233
页数:6
相关论文
共 185 条
[1]  
Iimura O(1996)Insulin resistance and hypertension in Japanese Hypertens Res 19 S1-8
[2]  
Sowers JR(2001)Diabetes, hypertension, and cardiovascular disease: an update Hypertension 37 1053-9
[3]  
Epstein M(2014)Type 2 diabetes mellitus and hypertension: an update Endocrinol Metab Clin North Am 43 103-22
[4]  
Frohlich ED(2008)Risk of type 2 diabetes mellitus in those with hypertension Eur Heart J 29 952-3
[5]  
Lastra G(2007)Blood pressure and risk of developing type 2 diabetes mellitus: the Women’s Health Study Eur Heart J 28 2937-43
[6]  
Syed S(2003)C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women Circulation 107 391-7
[7]  
Kurukulasuriya LR(2019)The role of genetic polymorphism in the formation of arterial hypertension, type 2 diabetes and their comorbidity Curr Pharm Des 25 218-27
[8]  
Manrique C(2021)Genome-wide and candidate gene association analyses identify a 14-SNP combination for hypertension in patients with type 2 diabetes Am J Hypertens 34 651-61
[9]  
Sowers JR(2020)Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 43 1617-35
[10]  
Das UN(2007)Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease Eur Heart J 28 3059-66